1.
Gazal S, Finucane HK, Furlotte NA, et al. Linkage disequilibrium-dependent architecture of human complex traits shows action of negative selection. Nat Genet. 2017;49(10):1421-1427. doi:10.1038/ng.3954.
1.
Guasch-Ferré M, Hu FB, Ruiz-Canela M, et al. Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study. J Am Heart Assoc. 2017;6(11). doi:10.1161/JAHA.117.006524.
1.
Spracklen CN, Saftlas AF, Triche EW, et al. Genetic Predisposition to Dyslipidemia and Risk of Preeclampsia. Am J Hypertens. 2015;28(7):915-23. doi:10.1093/ajh/hpu242.
1.
Kalim S, Clish CB, Wenger J, et al. A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. J Am Heart Assoc. 2013;2(6):e000542. doi:10.1161/JAHA.113.000542.
1.
Hohman TJ, Cooke-Bailey JN, Reitz C, et al. Global and local ancestry in African-Americans: Implications for Alzheimer’s disease risk. Alzheimers Dement. 2016;12(3):233-43. doi:10.1016/j.jalz.2015.02.012.
1.
Choi E-K, Park JH, Lee J-Y, et al. Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success. J Am Heart Assoc. 2015;4(8):e002046. doi:10.1161/JAHA.115.002046.
1.
Xu Q, Wu X, Li M, et al. Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population. Pharmacogenomics J. 2016;16(4):357-65. doi:10.1038/tpj.2015.61.
1.
Cajanus K, Holmström EJ, Wessman M, Anttila V, Kaunisto MA, Kalso E. Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer. Pain. 2016;157(2):361-9. doi:10.1097/j.pain.0000000000000398.
1.
Sklar P, Gabriel SB, McInnis MG, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry. 2002;7(6):579-93. doi:10.1038/sj.mp.4001058.